Literature DB >> 19568881

Immunological alterations found in mesothelioma patients and supporting experimental evidence.

Yoshie Miura1, Yasumitsu Nishimura, Megumi Maeda, Shuko Murakami, Hiroaki Hayashi, Kazuya Fukuoka, Takumi Kishimoto, Takashi Nakano, Takemi Otsuki.   

Abstract

It is common knowledge that exposure to asbestos causes asbestos-related diseases, such as asbestosis, lung cancer and malignant mesothelioma, not only in people who have had long-term contact with asbestos in their work environment but also in residents living near factories that handle asbestos. Since the summer of 2005, these revelations turned into a large medical problem and caused and social unrest. We have focused on the immunological effects of both asbestos and silica on the human immune system. In this brief review, we introduce immunological alterations found in patients with malignant mesothelioma and describe the experimental background in which these were found. Analyzing the immunological effects of asbestos may improve our understanding of the biological effects of asbestos.

Entities:  

Year:  2008        PMID: 19568881      PMCID: PMC2698266          DOI: 10.1007/s12199-007-0012-y

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  30 in total

1.  Rheumatoid pneumoconiosis in a foundry worker.

Authors:  A CAPLAN; E D COWEN; J GOUGH
Journal:  Thorax       Date:  1958-09       Impact factor: 9.139

Review 2.  T-cell receptor in Sjögren's syndrome.

Authors:  T Sumida; I Matsumoto; T Maeda; K Nishioka
Journal:  Br J Rheumatol       Date:  1997-06

3.  Transforming growth factor beta production by spontaneous malignant mesothelioma cell lines derived from Fisher 344 rats.

Authors:  M Kuwahara; M Takeda; Y Takeuchi; M Kuwahara; T Harada; K Maita
Journal:  Virchows Arch       Date:  2001-05       Impact factor: 4.064

4.  Inhibitory effects of anti-oxidants on apoptosis of a human polyclonal T-cell line, MT-2, induced by an asbestos, chrysotile-A.

Authors:  F Hyodoh; A Takata-Tomokuni; Y Miura; H Sakaguchi; T Hatayama; S Hatada; H Katsuyama; Y Matsuo; T Otsuki
Journal:  Scand J Immunol       Date:  2005-05       Impact factor: 3.487

5.  Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T cells.

Authors:  Yoshie Miura; Yasumitsu Nishimura; Hironobu Katsuyama; Megumi Maeda; Hiroaki Hayashi; Maolong Dong; Fuminori Hyodoh; Masafumi Tomita; Yoshinobu Matsuo; Ayuko Uesaka; Kozo Kuribayashi; Takashi Nakano; Takumi Kishimoto; Takemi Otsuki
Journal:  Apoptosis       Date:  2006-10       Impact factor: 4.677

Review 6.  Silicone breast implants and autoimmune disease.

Authors:  S L Brown; J J Langone; L A Brinton
Journal:  J Am Med Womens Assoc (1972)       Date:  1998

Review 7.  The epidemiology of asbestos-related diseases.

Authors:  Jacek Niklinski; Wieslawa Niklinska; Elzbieta Chyczewska; Jerzy Laudanski; Wojciech Naumnik; Lech Chyczewski; Eric Pluygers
Journal:  Lung Cancer       Date:  2004-08       Impact factor: 5.705

8.  Platelet-derived growth factor (PDGF) BB acts as a chemoattractant for human malignant mesothelioma cells via PDGF receptor beta-integrin alpha3beta1 interaction.

Authors:  J Klominek; B Baskin; D Hauzenberger
Journal:  Clin Exp Metastasis       Date:  1998-08       Impact factor: 5.150

Review 9.  Asbestos-related diseases of the lungs and pleura: uses, trends and management over the last century.

Authors:  M R Becklake; E Bagatin; J A Neder
Journal:  Int J Tuberc Lung Dis       Date:  2007-04       Impact factor: 2.373

10.  Transforming growth factor-beta: antisense RNA-mediated inhibition affects anchorage-independent growth, tumorigenicity and tumor-infiltrating T-cells in malignant mesothelioma.

Authors:  D R Fitzpatrick; H Bielefeldt-Ohmann; R P Himbeck; A G Jarnicki; A L Marzo; B W Robinson
Journal:  Growth Factors       Date:  1994       Impact factor: 2.511

View more
  5 in total

1.  Cytokine alteration and speculated immunological pathophysiology in silicosis and asbestos-related diseases.

Authors:  Shuko Murakami; Yasumitsu Nishimura; Megumi Maeda; Naoko Kumagai; Hiroaki Hayashi; Ying Chen; Masayasu Kusaka; Takumi Kishimoto; Takemi Otsuki
Journal:  Environ Health Prev Med       Date:  2009-03-18       Impact factor: 3.674

Review 2.  Silica exposure and altered regulation of autoimmunity.

Authors:  Suni Lee; Hidenori Matsuzaki; Naoko Kumagai-Takei; Kei Yoshitome; Megumi Maeda; Ying Chen; Masayasu Kusaka; Kozo Urakami; Hiroaki Hayashi; Wataru Fujimoto; Yasumitsu Nishimura; Takemi Otsuki
Journal:  Environ Health Prev Med       Date:  2014-08-19       Impact factor: 3.674

Review 3.  Asbestos induces reduction of tumor immunity.

Authors:  Naoko Kumagai-Takei; Megumi Maeda; Ying Chen; Hidenori Matsuzaki; Suni Lee; Yasumitsu Nishimura; Junichi Hiratsuka; Takemi Otsuki
Journal:  Clin Dev Immunol       Date:  2011-10-04

Review 4.  Nonpulmonary outcomes of asbestos exposure.

Authors:  Melisa Bunderson-Schelvan; Jean C Pfau; Robert Crouch; Andrij Holian
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

5.  Functional properties of CD8(+) lymphocytes in patients with pleural plaque and malignant mesothelioma.

Authors:  Naoko Kumagai-Takei; Yasumitsu Nishimura; Megumi Maeda; Hiroaki Hayashi; Hidenori Matsuzaki; Suni Lee; Takumi Kishimoto; Kazuya Fukuoka; Takashi Nakano; Takemi Otsuki
Journal:  J Immunol Res       Date:  2014-06-18       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.